Debate Escalates Over WHO Cancer Drugs Pricing Report
Executive Summary
A new report by the World Health Organization on the spiralling prices of cancer medicines has resulted in public health advocates demanding action against this fast-developing global crisis. The pharmaceutical industry, however, thinks the report is a missed opportunity for taking a more long-term and holistic approach.